Since its approval in mid-March of 2024, sales of Rezdiffra are increasing expediciously, reaching $62.2 million in Q3, the drug's first full quarter on the market. A mere year ago, Madrigal had no ...

Apple's generative AI offerings may not be quite as game-changing as the earlier hype implied. However, there's a takeaway ...

See? Amazing. (Remember that the S&P 500 has averaged annual gains of close to 10% over many decades -- and it's hard to beat ...

The Frontier purchase will be an all-cash transaction valued at $20 billion. According to media reports, Verizon looks to ...

Eli Lilly's weight loss drug sales in Q3 weren't as strong as it anticipated. Its earnings will continue to grow at a rapid ...

It's also worth noting that even after GM's surge in 2024, the stock still trades at a paltry price-to-earnings ratio of 5.8 ...

Nvidia stock has risen significantly due to the AI narrative, and I'm curious to see the progress of the company's new share ...

Brookfield Infrastructure ( BIPC 0.47%) ( BIP 0.23%) has been a standout dividend stock since its formation 15 years ago. The ...

Buffett trimmed his Apple stake by about a quarter in the last few months. The company had a solid recent earnings report, ...

Brookfield Renewable recently reported its third-quarter results. The company generated $278 million, or $0.42 per share, in ...

Nvidia will report financial results for the third quarter on Nov. 20, and the vast majority of Wall Street analysts rate the ...

Growth stocks have led the S&P 500 to record highs this year. This fund is a way to invest in many of today’s winners. This ...